Shoker Investment Counsel, Inc. Palatin Technologies Inc Transaction History

Shoker Investment Counsel, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 11, 2021	SELL	$0.68 - $1.25 $13,600 - $25,000	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.38 - $0.78 $7,600 - $15,600	20,000 New	20,000 $13,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Shoker Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Shoker Investment Counsel, Inc. with notifications on news.